"Cushing Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
Concept/Terms
Cushing Syndrome- Cushing Syndrome
- Syndrome, Cushing
- Cushing's Syndrome
- Syndrome, Cushing's
- Hypercortisolism
Below are MeSH descriptors whose meaning is more general than "Cushing Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Cushing Syndrome".
This graph shows the total number of publications written about "Cushing Syndrome" by people in Harvard Catalyst Profiles by year, and whether "Cushing Syndrome" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 4 | 1 | 5 |
| 1993 | 1 | 1 | 2 |
| 1994 | 2 | 1 | 3 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 2 | 4 |
| 1998 | 5 | 0 | 5 |
| 1999 | 4 | 2 | 6 |
| 2000 | 8 | 1 | 9 |
| 2001 | 1 | 1 | 2 |
| 2002 | 5 | 2 | 7 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 2 | 2 | 4 |
| 2006 | 1 | 1 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 8 | 1 | 9 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 4 | 3 | 7 |
| 2012 | 5 | 0 | 5 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 3 | 0 | 3 |
| 2018 | 5 | 0 | 5 |
| 2019 | 3 | 1 | 4 |
| 2020 | 6 | 0 | 6 |
| 2021 | 5 | 0 | 5 |
Below are the most recent publications written about "Cushing Syndrome" by people in Profiles.
-
Diagnostic Impact of Adrenal Vein Sampling in Adrenal Cushing's Syndrome. J Surg Res. 2021 12; 268:660-666.
-
Characterization of Outcomes by Surgical Management of Lung Neuroendocrine Tumors Associated With Cushing Syndrome. JAMA Netw Open. 2021 09 01; 4(9):e2124739.
-
Levoketoconazole: a novel treatment for endogenous Cushing's syndrome. Expert Rev Endocrinol Metab. 2021 07; 16(4):159-174.
-
Casting a Wide Net. N Engl J Med. 2021 Apr 01; 384(13):e50.
-
Adrenally Directed Medical Therapies for Cushing Syndrome. J Clin Endocrinol Metab. 2021 01 01; 106(1):16-25.
-
Kisspeptin deficiency leads to abnormal adrenal glands and excess steroid hormone secretion. Hum Mol Genet. 2020 12 18; 29(20):3443-3450.
-
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome. Pituitary. 2021 Feb; 24(1):104-115.
-
Disseminated cryptococcosis in a patient with adrenocortical carcinoma and Cushing's syndrome. J Infect Chemother. 2020 Dec; 26(12):1301-1304.
-
Dietary sodium intake and cortisol measurements. Clin Endocrinol (Oxf). 2020 11; 93(5):539-545.
-
COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol. 2020 08; 8(8):654-656.